Abstract Library
Welcome to the open-access search for all ENETS abstracts presented at the Annual ENETS Conferences.
Everyone can browse the library to find basic information on abstracts. To get full access to each entry, you will be asked to log in to your myENETS account.
ENETS Abstract Search
Introduction: Bronchial neuroendocrine neoplasms (NENs) can be subdivided into TCs, ACs and neuroendocrine carcinomas (NECs). Although a few studies have explored treatment approaches and oncological outcomes, most focus on surgical cohorts, small sample sizes, or mixed groups including TC, AC, and NECs. Real-life cohort data are lacking.
Conference:
Presenting Author: Clement D
Authors: Correia J, Sarker D, Dolly S, Frydman A, Srirajaskanthan R,
Keywords: bronchial carcinoid, treatment pattern, recurrence-free survival, overall survival,
Introduction: Malnutrition is common in patients with gastroenteropancreatic neuroendocrine tumours (GEP-NETs) treated with monthly somatostatin analogues (SSAs). Ideally all malnourished patients are offered nutritional support. However, clinical guidelines and data on the development and progression of malnutrition is lacking.
Conference:
Presenting Author: Clement D
Authors: Soran V, Srirajaskanthan R, Cananea E, Martin W, Minott S,
Keywords: gastroenteropancreatic neuroendocrine tumour, malnutrition, somatostatin analogue,
#4646 Dysregulated miRNA in patients with GEP-NEN and potential role as circulating biomarker
Introduction: Neuroendocrine neoplasms (NENs) are a class of rare and molecularly extremely heterogeneous tumours. NENs arise predominantly in the gastrointestinal (GEP) and pulmonary tracts but can also involve thyroid and breast. NENs often present with non-specific symptoms and lack early specific biomarkers, leading to frequent metastatic diagnoses and primary site challenges.
Conference:
Presenting Author:
Authors: Di Mauro A, Clemente O, Cannella L, Della Vittoria G, Neri G,
Keywords: neuroendocrine tumour, miRNome profiling, biomarker, gep-net, molecular biology,
Introduction: Tuberous sclerosis (TSC) is an autosomal dominant condition which can increase the risk of pancreatic neuroendocrine tumours (PanNETs) (1). Patients with TSC undergo screening for renal tumours which may include pancreatic imaging (2). There are currently no screening guidelines for PanNETs in patients with TSC.
Conference:
Presenting Author: Frydman A
Authors: Frydman A, Clement D, Srirajaskanthan R,
Keywords: Pancreas neuroendocrine tumour, Tuberous sclerosis,
Introduction: Pancreatic neuroendocrine tumours (PanNETs) are the leading cause of death in patients (pts) with MEN1. Screening is recommended to diagnose early and prevent metastases. The optimal cut-off of when to intervene in a PanNET is still an area of debate.
Conference:
Presenting Author: Frydman A
Authors: Frydman A, Clement D, Srirajaskanthan R,